VitaRNA
VITARNA
Evaluation Score
Overall rating on a scale of 0-10
Dimension Breakdown
AI Analysis
Comprehensive evaluation of the token
VITARNA (VitaRNA) is an IP-NFT tokenization of an Artan Bio gene therapy research project incubated within the VitaDAO and Molecule ecosystem on Ethereum. Data gaps were identified in Active Development and Community Support (both scored -1.0) due to a lack of verified independent project repositories and dedicated community channels, requiring weight redistribution among the remaining categories. Tokenomics score 3.5/10 reflects that while 20% of the 5M genesis supply was sold via a crowdsale to VITA holders with a 12-month vest, the remaining 80% allocation and unlock schedules remain undisclosed, and utility is limited to niche IP governance. Market and Use Case scores 1.5/10 due to extreme micro-cap status ($1.8M market cap) with negligible daily trading volume ($3.3K-$10.5K on Uniswap), creating severe liquidity risks. Team and Governance scores 4.5/10 based on VitaDAO ecosystem affiliation despite anonymous individual team members and undocumented project governance. Security and Audit History scores 2.5/10 due to the absence of independent smart contract audits or platform ratings, though no exploits, hacks, or regulatory actions were recorded. No qualifying red-flag cap applies.
Development Activity
Code updates and developer engagement
Community Support
Social media presence and community engagement
Tokenomics
Supply, distribution, and utility
Market & Use Case
Value proposition and competitive landscape
Team & Governance
Team background and project governance
Security & Audits
Security history and audit status
About VitaRNA (VITARNA)
VITARNA (VitaRNA) is an intellectual property (IP) token representing the tokenization of an Artan Bio gene therapy research project. Incubated within the VitaDAO and Molecule ecosystem, the token operates on the Ethereum blockchain. VITARNA was minted against the Artan Bio IP-NFT to provide holders with research governance and voting rights over the underlying tokenized scientific intellectual property.
The project established a genesis supply of 5,000,000 tokens. During its initial distribution, 20% of the total supply was sold to VITA token holders through a $300,000 fixed-price crowdsale subject to a 12-month vesting period. VITARNA's utility is focused on IP governance, lacking mechanisms for staking, fee capture, or programmatic token burns. Trading activity for the token takes place primarily on decentralized markets via Uniswap.
Several structural and market risks are associated with the project. Although no hacks, exploits, or regulatory enforcement actions have been documented, the VITARNA smart contract has not undergone an independent security audit. Furthermore, the allocation and release schedules for the remaining 80% of the token supply remain undisclosed. VITARNA operates as a micro-cap asset with a market capitalization of approximately $1.8 million and low daily trading volumes between $3.3 thousand and $10.5 thousand, leading to substantial liquidity risk. Individual team members and standalone project-level governance documentation are also undisclosed.